Donaperminogene seltoplasmid

DB17931InvestigationalGene Therapies

Donaperminogene seltoplasmid: Overview.

Mechanism: Pharmacologically active on Hepatocyte growth factor receptor
Curator reviewed
Code names: NL003 · pCK-HGF-X7 · VM-202

Resolves to

Compound

Targets

What you can answer from here — as of October 05, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

21Clinical trialsPhase, status and sponsor resolved per trial

4+ReferencesStructured and connected to the statements they support

Which drugs share a target with Donaperminogene seltoplasmid, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.